Balchem Corporation
General ticker "BCPC" information:
- Sector: Materials
- Industry: Chemicals - Specialty
- Capitalization: $5.2B (TTM average)
Balchem Corporation follows the US Stock Market performance with the rate: 15.4%.
Estimated limits based on current volatility of 1.3%: low 155.01$, high 158.94$
Factors to consider:
- Company pays dividends (annually): last record date 2025-12-23, amount 0.96$ (Y0.61%)
- Total employees count: 1361 as of 2024
- US accounted for 75.8% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Operational and conduct risks, Cybersecurity threats, Currency fluctuations, Interest rate risk, Acquisition/divestiture risks
- Earnings for 3 months up through Q1 are close to our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [125.33$, 172.34$]
- 2026-12-31 to 2027-12-31 estimated range: [132.46$, 180.43$]
Financial Metrics affecting the BCPC estimates:
- Negative: with PPE of 30.4 at the end of fiscal year the price was high
- Positive: Operating profit margin, % of 20.18 > 18.39
- Negative: Industry operating cash flow per share per price (median), % of 5.08 <= 5.46
- Positive: -4.41 < Investing cash flow per share per price, % of -0.86
- Positive: Return on assets ratio (scaled to [-100,100]) of 8.41 > 6.06
- Positive: -0.02 < Operating cash flow per share per price, % of 4.24
- Negative: Industry earnings per price (median), % of 2.55 <= 4.45
- Positive: -9.55 < Industry operating profit margin (median), % of 2.39
- Positive: Industry inventory ratio change (median), % of -0.12 <= 0
- Positive: Inventory ratio change, % of -0.81 <= -0.75
- Positive: Shareholder equity ratio, % of 74.57 > 64.29
Short-term BCPC quotes
Long-term BCPC plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $922.44MM | $953.68MM | $1,037.16MM |
| Operating Expenses | $763.25MM | $770.77MM | $827.84MM |
| Operating Income | $159.19MM | $182.91MM | $209.33MM |
| Non-Operating Income | $-21.93MM | $-16.46MM | $-10.30MM |
| Interest Expense | $22.61MM | $16.53MM | $10.22MM |
| R&D Expense | $15.05MM | $16.79MM | $18.51MM |
| Income(Loss) | $137.26MM | $166.45MM | $199.03MM |
| Taxes | $28.72MM | $37.98MM | $44.19MM |
| Net Income(Loss)* | $108.54MM | $128.47MM | $154.84MM |
| Stockholders Equity | $1,053.98MM | $1,149.91MM | $1,257.41MM |
| Inventory | $109.52MM | $130.80MM | $131.45MM |
| Assets | $1,597.21MM | $1,575.37MM | $1,686.25MM |
| Operating Cash Flow | $183.76MM | $182.00MM | $216.56MM |
| Capital expenditure | $37.89MM | $35.66MM | $43.49MM |
| Investing Cash Flow | $-34.81MM | $-59.74MM | $-43.89MM |
| Financing Cash Flow | $-153.32MM | $-133.81MM | $-152.81MM |
| Earnings Per Share** | $3.38 | $3.97 | $4.75 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.